Temozolomide and Reirradiation in Recurrent Grade II Brain Glioma

World Journal of Oncology - Canada
doi 10.14740/wjon838w
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Elmer Press, Inc.

Related search

Combination of 6-Thioguanine, Capecitabine, and Celecoxib With Temozolomide or Lomustine for Recurrent High-Grade Glioma

Journal of Neuro-Oncology
Cancer ResearchOncologyNeurology
2010English

Erratum To: Radiosurgery Reirradiation for High-Grade Glioma Recurrence: A Retrospective Analysis

Neurological Sciences
DermatologyMedicinePsychiatryNeurologyMental Health
2015English

A Probabilistic Atlas of Diffuse WHO Grade II Glioma Locations in the Brain

PLoS ONE
Multidisciplinary
2016English

Dose Dense 1 Week on/1 Week Off Temozolomide in Recurrent Glioma: A Retrospective Study

Journal of Neuro-Oncology
Cancer ResearchOncologyNeurology
2012English

Phase II Trial of Temozolomide in Low-Grade Non-Hodgkin's Lymphoma

British Journal of Cancer
Cancer ResearchOncology
1995English

Phase II Study of Bevacizumab and Vorinostat for Patients With Recurrent World Health Organization Grade 4 Malignant Glioma

Oncologist
Cancer ResearchMedicineOncology
2017English

A Thought-Provoking Retrospective Study on Survival and Toxicity After Reirradiation for Recurrent High-Grade Gliomas

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2011English

Hypofractionated Stereotactic Radiation Therapy in Recurrent High-Grade Glioma: A New Challenge

Cancer Research and Treatment
Cancer ResearchOncology
2016English

Timing of Surgery and Bevacizumab Therapy in Neurosurgical Patients With Recurrent High Grade Glioma

Journal of Clinical Neuroscience
MedicineSurgeryNeurologyPhysiology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy